Key Achievements of the Last Decade and Future Prospects in Cardiovascular Disease
A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Medical Research".
Deadline for manuscript submissions: closed (1 June 2022) | Viewed by 2467
Special Issue Editor
Special Issue Information
Dear Colleagues,
In the last decade, cardiology has made many advances with the results of intensive research and evidence-based medicine allowing us to have a more robust knowledge base. Progress is being made both in terms of the diagnosis and understanding of cardiovascular pathology, and in terms of treatment, exemplified by the development of minimally invasive technologies that have enabled more patients to be treated for heart problems successfully. Among the greatest accomplishments have been the replacement of surgical approaches by percutaneous methods for almost all types of structural heart disease.
Progress in treatment was made through the emergence of new drugs or by better understanding old ones. One such treatment is the use of non-vitamin K antagonists in the cardiovascular field for stroke prevention and venous thombo-embolic disease, for which we have now four non-vitamin K oral anticoagulants as alternatives to the only treatment that was previously available, warfarin. Perhaps the most stunning pharmacological developments have been the PCSK9 inhibitors (alirocumab and evolocumab), which dramatically lower LDL-cholesterol and sacubitril/valsartan or SGLT2, which reduces risk of cardiovascular death and heart-failure-related hospitalization as well as GLP-1RA in diabetic patients with cardiovascular pathology.
Recent years have also been marked by the development of new branches such as cardio-oncology to find a balance between the effectiveness of cancer treatment and the prevention of cardiovascular complications, which are currently extremely numerous.
In this Special Issue, we will summarize the achievements of the last decade and forecast the future in cardiovascular disease. We welcome communications, reviews and original research articles.
Prof. Dr. Daniel Lighezan
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cardiovascular
- heart disease
- anticoagulants
- dyslipidemia
- treatment
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
